Abstracts tagged "pain and sleep"

Abstract Number: 261 • 2018 ACR/ARHP Annual Meeting
Mindfulness Is Associated with Sleep Quality Among Patients with Fibromyalgia
Michelle Park¹, Yuan Zhang², Lori Lyn Price^3,4, Raveendhara R. Bannuru¹ and Chenchen Wang¹, ¹Division of Rheumatology, Center for Complementary and Integrative Medicine, Tufts Medical Center, Boston, MA, ²Susan and Alan Solomont School of Nursing, University of Massachusetts Lowell, Lowell, MA, ³Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁴Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA
Background/Purpose: Poor and disturbed sleep is an important disabling feature of fibromyalgia. Previous studies suggest higher mindfulness may be associated with better sleep quality in…
Abstract Number: 1530 • 2017 ACR/ARHP Annual Meeting
Improvements in Sleep Problems and Pain in Patients with Active Ankylosing Spondylitis Treated with Intravenous Golimumab: 28-Week Results of the Phase III Trial
Atul A. Deodhar¹, John D. Reveille², Eric K. H. Chan³, Steven Peterson⁴, Nan Li⁴, Elizabeth C. Hsia⁵, Lilianne Kim⁴, Kim Hung Lo⁴, Diane D. Harrison⁴ and Chenglong Han⁶, ¹Division of Arthritis & Rheumatic Diseases OP09, Oregon Health & Science University, Portland, OR, ²University of Texas McGovern Medical School, Houston, TX, ³Janssen Global Services, LLC, Raritan, NJ, ⁴Janssen Research & Development, LLC, Spring House, PA, ⁵Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA, ⁶Janssen Global Services, LLC, Malvern, PA
Background/Purpose: To investigate the effect of intravenously administered (IV) golimumab (GLM, 2 mg/kg), an anti-TNFα monoclonal antibody, on sleep problems, total back pain (TBP), and…
Abstract Number: 49 • 2016 ACR/ARHP Annual Meeting
Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study
Domenico Merante¹, Julio Rosenstock², Uma Sharma³, Karen Feins⁴, Ching Hsu⁵ and Aaron Vinik⁶, ¹Daiichi Sankyo Development Ltd, Gerrards Cross, Buckinghamshire, United Kingdom, ²Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, ³MMS Holdings Inc., Canton, MI, ⁴Daiichi Sankyo Pharma Development, Edison, NJ, ⁵Daiichi Sankyo Inc, Edison, NJ, ⁶Eastern Virginia Medical School, Norfolk, VA
Background/Purpose: Mirogabalin is a novel, preferentially selective a2d-1 ligand intended for treatment of pain associated with fibromyalgia and neuropathic pain. Mirogabalin efficacy and safety was…
Abstract Number: 1475 • 2015 ACR/ARHP Annual Meeting
Fatigue, Quality of SLEEP and PAIN in Children with Juvenile Idiopathic Arthritis
Ela Tarakci¹, Saime Nilay Baydogan², Kenan Barut³ and Ozgur Kasapcopur⁴, ¹Division of Physiotherapy and Rehabilitation, Faculty of Health Science, Istanbul University,, Associate Professor, Istanbul, Turkey, ²Division of Physiotherapy and Rehabilitation, Faculty of Health Science, Istanbul University,, Assistant Professor, Istanbul, Turkey, ³Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey, ⁴Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Professor of Pediatric Rheumatology, Istanbul, Turkey
Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is one of the most common rheumatic diseases in childhood, affecting at least 1 in 1000 children (1). Children with…
Abstract Number: 1116 • 2014 ACR/ARHP Annual Meeting
Mindfulness Is Associated with Sleep Quality Among Patients with Fibromyalgia
Yuan Zhang¹, Lori Lyn Price², Nani Morgan³, Lucas Morgan⁴ and Chenchen Wang⁵, ¹School of Nursing, University of Massachusetts Lowell, Lowell, MA, ²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ³Internal Medicine Residency Program, University of Hawaii, Honolulu, HI, ⁴Clinical Psychology, University of Massachusetts, Honolulu, HI, ⁵Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Mindfulness is the ability to observe, describe, or be aware of present moment experiences without judgment or reactivity. Previous literature suggests that mindfulness-based interventions…
Abstract Number: 135 • 2013 ACR/ARHP Annual Meeting
Evaluation Of The Quality Of Life and Sleep In Patients With Benign Joint Hypermobility Syndrome
Ilknur Albayrak¹, Halim Yilmaz¹, Ekrem Akkurt², Ali Salli³ and Gulten Karaca⁴, ¹The Department of Physical Medicine and Rehabilitation, Konya Education and Research Hospital, MD, Konya, Turkey, ²The Department of Physical Medicine and Rehabilitation, Konya Education and Research Hospital, Konya, Turkey, MD, Konya, Turkey, ³The Department of Physical Medicine and Rehabilitation, Necmettin Erbakan University, Meram Faculty of Medicine, MD, KONYA, Turkey, ⁴1The Department of Physical Medicine and Rehabilitation, Konya Education and Research Hospital, Konya, Turkey, MD, Konya, Turkey
Background/Purpose: Traction injuries at tendon or ligament attachment sites, joint instability, low back, back and neck pain can be seen in patients with benign joint…
Abstract Number: 2641 • 2012 ACR/ARHP Annual Meeting
Time-to-Improvement of Pain and Sleep in Clinical Trials of Pregabalin Treatment of Fibromyalgia
Lesley M. Arnold¹, Andrew Clair², Birol Emir², Lynne Pauer² and E. Malca Resnick², ¹Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, ²Pfizer Inc, New York, NY
Background/Purpose: Fibromyalgia (FM) is a chronic condition characterized by widespread pain and tenderness. Sleep disturbance is common in patients with FM, and both pain and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].